ICU Medical Inc.

NASDAQ: ICUI · Real-Time Price · USD
120.35
8.45 (7.55%)
At close: Aug 15, 2025, 12:49 PM

ICU Medical Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Infusion Consumables Revenue 1.04B 969.13M 566.62M 555.19M 473.74M 477.61M 483.04M
Infusion Consumables Revenue Growth n/a n/a +2.06% +17.19% -0.81% -1.12% n/a
Infusion Systems Revenue 652.41M 629.04M 351.08M 352.32M 359.69M 328.28M 355.48M
Infusion Systems Revenue Growth n/a n/a -0.35% -2.05% +9.57% -7.65% n/a
Vital Care Revenue 690.77M 660.95M 284.61M n/a n/a n/a n/a
Vital Care Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Emea Revenue 393.53M 373.57M 257.21M 147.49M 132.76M 130.53M 134.36M 54.47M
Emea Revenue Growth +5.34% +45.24% +74.39% +11.09% +1.71% -2.85% +146.70% n/a
Other Foreign Countries Revenue 223.59M 203.84M 367.41M 227.01M 227.61M 212.34M 211M 30.18M
Other Foreign Countries Revenue Growth +9.69% -44.52% +61.85% -0.26% +7.20% +0.64% +599.03% n/a
United States Revenue 1.53B 1.44B 195.31M 941.81M 910.63M 923.34M 1.05B 979.94M
United States Revenue Growth +6.39% +637.30% -79.26% +3.42% -1.38% -12.45% +7.63% n/a
Asia Pacific Revenue 232M 241.7M 1.46B n/a n/a n/a n/a n/a
Asia Pacific Revenue Growth -4.01% -83.45% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 159.39M 157.23M 158.85M 162.71M 159.55M 157.66M 154.62M 148.61M 150.9M 152.57M 142.93M 153.45M 158.75M 153.21M 81.46M 74.81M 73.92M 72.39M 73.55M 70.85M 67.24M 72.31M 70.65M 65.88M 67.82M 72.63M 79.54M 78.07M 83.54M 87M 77.14M 76.82M 85.11M 64.89M 22.6M 22.36M 22.49M 21.98M 22.52M 20.21M 20.32M 20.17M
Selling, General, and Administrative Revenue Growth +1.37% -1.02% -2.37% +1.98% +1.20% +1.97% +4.04% -1.51% -1.10% +6.74% -6.85% -3.34% +3.61% +88.09% +8.88% +1.21% +2.11% -1.58% +3.81% +5.37% -7.00% +2.34% +7.25% -2.87% -6.62% -8.69% +1.89% -6.55% -3.98% +12.78% +0.42% -9.74% +31.16% +187.13% +1.06% -0.57% +2.35% -2.42% +11.45% -0.55% +0.71% n/a
Research and Development Revenue 21.87M 23.29M 22.36M 21.03M 23.39M 21.84M 22.41M 20.87M 22.3M 19.76M 23.45M 23.11M 22.56M 23.87M 13.17M 12.24M 11.38M 10.71M 11.8M 10.13M 10.28M 10.75M 12.59M 12M 11.2M 12.82M 13.53M 13.18M 13.57M 12.59M 13.88M 12.77M 12.97M 11.64M 2.65M 3.65M 3.34M 3.31M 4.06M 4.23M 3.12M 4.31M
Research and Development Revenue Growth -6.11% +4.19% +6.31% -10.10% +7.09% -2.54% +7.38% -6.42% +12.86% -15.72% +1.48% +2.41% -5.48% +81.31% +7.58% +7.49% +6.31% -9.22% +16.50% -1.49% -4.35% -14.63% +4.87% +7.17% -12.66% -5.19% +2.61% -2.90% +7.86% -9.30% +8.67% -1.53% +11.39% +338.62% -27.29% +9.35% +0.75% -18.34% -4.02% +35.39% -27.53% n/a